Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Long-Term Effects of Sucontral(TM) on Mild and Moderate Cases of Diabetes Mellitus (Type 2)

This study has been completed.
Information provided by:
Harras Pharma Curarina GmbH Identifier:
First received: April 18, 2006
Last updated: NA
Last verified: April 2006
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: June 2005
  Estimated Primary Completion Date: No date given